Searcharxiv⌕ Search

arXiv subjects

Myung Jin Park

Publications and source records attributed to Myung Jin Park.

2 recordsLinked to original sources

Electron-wave-stimulated mid-infrared emission from graphene-substrate quantum oscillators

Generating tunable, high-intensity mid-infrared (MIR) to terahertz (THz) radiation on-chip remains a formidable challenge due to the rigid spectral limits of conventional thermal emitters. While graphene has emerged as a promising platform for light-matter interaction, active control of its radiative properties has been largely confined to surface-limited phenomena mostly associated with plasmons. Here, we introduce a new MIR radiation platform where multi-layer chemical vapor deposition (CVD) graphene is integrated with modular, vibrationally active dielectric substrates, ranging from organic thin films and inorganic matrices. A pivotal discovery is that the long-range de Broglie wavelength of drift carriers enables coherent coupling with vibrational transition dipoles deep within the substrate bulk. This transforms the substrate into a three-dimensional volume emission source, where complex spectra of characteristic molecular and lattice vibration energies are additively combined on demand. The exponential scaling of radiation intensity appears when the electrons' drift velocity in graphene exceeds the sound velocity of the substrates, consistent with quantum stimulated amplification associated with Cerenkov electron-phonon instability. Our work redefines the passive dielectric substrate as an active, programmable component driven by electron waves, paving the way for next-generation system-on-a-chip MIR-THz photonics, environmental and biomedical sensing, and highly efficient mode-specific electrothermal applications.

physics.chem-ph↗

Graphene quantum dots prevent alpha-synucleinopathy in Parkinson's disease

While the emerging evidence indicates that the pathogenesis of Parkinson's disease (PD) is strongly correlated to the accumulation of alpha-synuclein (α-syn) aggregates, there has been no clinical success in anti-aggregation agents for the disease to date. Here we show that graphene quantum dots (GQDs) exhibit anti-amyloid activity via direct interaction with α-syn. Employing biophysical, biochemical, and cell-based assays as well as molecular dynamics (MD) simulation, we find that GQDs have notable potency in not only inhibiting fibrillization of α-syn but also disaggregating mature fibrils in a time-dependent manner. Remarkably, GQDs rescue neuronal death and synaptic loss, reduce Lewy body (LB)/Lewy neurite (LN) formation, ameliorate mitochondrial dysfunctions, and prevent neuron-to-neuron transmission of α-syn pathology induced by α-syn preformed fibrils (PFFs) in neurons. In addition, in vivo administration of GQDs protects against α-syn PFFs-induced loss of dopamine neurons, LB/LN pathology, and behavioural deficits through the penetration of the blood-brain barrier (BBB). The finding that GQDs function as an anti-aggregation agent provides a promising novel therapeutic target for the treatment of PD and related α-synucleinopathies.

physics.med-ph↗